Benzinga | Nov 23, 2021 04:33PM EST

Mirati Therapeutics To Participate In Evercore ISI HealthCONx Conference Dec. 2 At 2:15 p.m. EST

Mirati Therapeutics, Inc. (NASDAQ:MRTX), a clinical-stage targeted oncology company, will take part in a fireside chat at the Evercore ISI HealthCONx Conference, which will be webcast on December 2 at 11:15 a.m. P.T. / 2:15 p.m. E.T. David Meek, chief executive officer and Charles Baum, M.D., Ph.D., president, founder and head of research and development, will represent the company.

The webcast will be available through the "Investors and Media" section on Mirati.com and a replay of the webcast will be made available following the event.